Osteoarthritis (OA) is a debilitating condition characterized by joint cartilage degeneration and inflammation. Although the anti-inflammatory properties of Hydrangea serrata (Thunb.) Ser. (H. serrata) have been known, its full potential as a treatmen...
Osteoarthritis (OA) is a debilitating condition characterized by joint cartilage degeneration and inflammation. Although the anti-inflammatory properties of Hydrangea serrata (Thunb.) Ser. (H. serrata) have been known, its full potential as a treatment for OA, particularly using a standardized hot water extract of H. serrata (WHS), has not been thoroughly explored. This study was conducted to evaluate the anti-inflammatory and anti-arthritic properties of WHS in both cell-based models and animal models, focusing on its impact on the nuclear factor kappa-light-chain- enhancer of activated B cells (NF-κB) and mitogen-activated protein kinase (MAPK) pathways. In vitro, WHS reduced key inflammatory mediators (PGE2 and COX-2) and the mRNA expression of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in RAW 264.7 murine macrophages and SW1353 human chondrocytes. Furthermore, WHS effectively inhibited RANKL-induced osteoclastogenesis in RAW 264.7 macrophages, suggesting its potential in preventing bone degradation in OA. In vivo, WHS reduced paw swelling and inflammatory pain in carrageenan-induced paw edema and adjuvant-induced arthritis (AIA) rat models. These effects were associated with decreased phosphorylation of IκB kinase alpha/beta (IKKα/β) and MAPKs, as well as reduced expression of metalloproteinase-13 (MMP-13). These findings suggest that WHS is a promising therapeutic agent for OA and its associated inflammatory conditions.